Adrian
Investor at Zoic Capital
About
Adrian joined Zoic in 2021 after completing Harvard's Chemical Biology Program. He leads new investment reviews and analysis of over 1,000 health startups annually, oversees investment committee meetings, and develops IP strategy for portfolio companies. Adrian also serves as a Scientific Advisor to Creative Destruction Labs.